LAB LOGA page on LabLog, a review site (not the lab's official page)
先端分子治療学
Showing the original Japanese · View translation
ペリオスチンの病的な型を狙い、難しい病気の治療法を開発する研究室。
AboutAbout the lab
病的ペリオスチンを狙い、難治性疾患の治療法を開発。
先端分子治療学は、
ペリオスチンの
その
心不全、
Key terms
- ペリオスチン
- さまざまな
臓器に あり、 細胞の 増殖や 組織の 修復に 関わる タンパク質。 - スプライシングバリアント
- 遺伝子の
一部 （エクソン）が 抜けたり 残ったりして、 同じ 遺伝子から 生じる 複数の 型。 - 中和抗体
- 標的の
働きを 抑える抗体。 病的ペリオスチンだけを 狙う ものを 作っている。
NewsLab news
特任研究員が、
日本抗加齢医学会総会で 最優秀演題賞を 受賞 谷山教授が、
特別講演の 内容を 大阪保険医雑誌に 総説と して 発表 乳腺・内分泌外科学と
共同で、 病的ペリオスチン抗体の 臨床試験開始を 発表 共同研究者の
大学院生が、 日本口腔外科学会総会で 優秀演題賞を 受賞 正常組織と
乳がんでの ペリオスチンの 発現を 調べた 論文が、 Biomolecules誌に 掲載
ResearchResearch themes
心不全の
*Illustrative image心不全の悪化を抑える
ペリオスチンの
*Illustrative image動脈瘤ができる仕組み
さまざまな
*Illustrative imageがんの化学療法抵抗性
がん細胞が
*Illustrative image脳梗塞での保護効果
ペリオスチンの
MembersFaculty
先端分子治療学の
- Project Professor谷山 義明
VoicesStudent voices
Ratings and reviews reflect the experiences of individual current or former students, not the lab's official views. Whether a lab has reviews, or how many, says nothing about the lab itself.
Students who take part in an interview may receive a thank-you gift worth ¥1,000, regardless of what they say.
Student ratings (0 students)
--
--
--
--
--
--
Student voices answer questions like these
- What's great about this lab?
- What did you learn after joining?
- What's the vibe, and what is the professor like?
- Who is this lab for?
- Where do graduates go?
Your experience can help younger students choose their lab. Your name won't be shown.
Write a lab reviewAnonymous · Your draft is saved if you stopRelatedLabs similar to 先端分子治療学
臨床遺伝子治療学大学院医学系研究科 医学専攻難治性疾患に
疾患データサイエンス学大学院医学系研究科 医学専攻画期的な
視覚機能形成学大学院医学系研究科 医学専攻人工網膜を
代謝血管学大学院医学系研究科 医学専攻生活習慣病とThe information on this page is compiled by the LabLog team from the lab's public information and interviews. For corrections or removal requests, please contact LabLog, not the lab.
Report an errorAbout the images
The top and research theme images are illustrative and were not taken at the lab. They are cropped from Wikimedia Commons images. Cropped CC BY-SA images are provided under the same CC BY-SA license as the original (version shown on each line).
- Top image: “Cardiovascular system - Systolic heart failure -- Smart-Servier” Laboratoires Servier / CC BY-SA 3.0 (cropped)
- 心不全の
悪化を 抑える : “Cardiovascular system - Diastolic heart failure -- Smart-Servier” Laboratoires Servier / CC BY-SA 3.0 (cropped) - 動脈瘤が
できる 仕組み: “Diseased Blood Vessel Model ( )” The U.S. Food and Drug Administration / Public domain (cropped) - がんの
化学療法抵抗性: “Cancer stem cells model” Malymajo / CC BY-SA 3.0 (cropped) - 脳梗塞での
保護効果: “FLAIR MRI of cerebral infarction” edit Shazia Mirza and Sankalp Gokhale See also source article for additional image creators. / CC BY 4.0 (cropped) - Related lab (臨床遺伝子治療学): “AAV Gene Therapy” George Church / CC BY-SA 3.0 (cropped)
- Related lab (疾患データサイエンス学): “Cdnaarray” Mangapoco / CC BY 2.5 (cropped)
- Related lab (視覚機能形成学): “EpiretinalMembrane OCT” Jmarchn / CC BY-SA 3.0 (cropped)
- Related lab (代謝血管学): “Histopathology of coronary artery atherosclerosis, original” Mikael Häggström, M.D. Author info - Reusing images- Conflicts of interest: None Mikael Häggström, M.D.Consent note: Consent from the patient or patient's relatives is regarded as redundant, because of absence of identifiable features (List of HIPAA identifiers) in the media and case information (See also HIPAA case reports guidance). / CC0 (cropped)
About LabLog
LabLog is a lab review app for students only. Student members at each university interview students in labs and publish what they say. Student voices can only be read by students who sign up with a university email address. Operated by bestiee Inc.
Learn more about LabLog ↗Search engines and AI may reference the basic lab info and rating summaries on this page and the description of LabLog. Student voices are for student members only. Automated collection by programs (scraping, or input to or training of AI) is prohibited under Article 8 of the Terms of Service. If you need data for research or analysis, please contact us.